Metrogel
Drug - Metrogel
The trade name of the product as shown on the labeling.
Dosage -
GEL; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Metronidazole
Multiple ingredients are in alphabetical order.
Strength -
1%
The potency of the active ingredient(s), Metronidazole. May repeat for multiple part products.
Applicant -
GALDERMA LABS LP
The firm name holding legal responsibility for Metrogel. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
021789
The FDA assigned number to Metrogel. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Metrogel. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jun 30, 2005
The date Metrogel was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Metrogel. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Metrogel is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Galderma Laboratories Lp
The full name of the firm holding legal responsibility for the new application of Metrogel.
Metrogel
|
